Axim Biotechnologies has announced the appointment of Mauricio Javier Gatto-Bellora to its Board of Directors.
“Mauricio Javier Gatto-Bellora has an extensive track record of leading companies through international expansion and will be valuable to Axim as the company continues to expand and move forward with our clinical development program,” said John W. Huemoeller II, CEO of Axim Biotech. “Axim is moving forward in its pipeline of pharmaceutical and nutraceutical products with some products slated to hit the market as soon as next quarter. We look forward to what we can accomplish internationally with Gatto-Bellora’s expertise.”
Gatto-Bellora is Founder and President of Hair Ventures. He has more than three decades of experience in the pharma, biochemistry and cosmetics industries including roles at prominent companies such as Mary Kay, Natura and Allergan. He replaces Blake N Schroeder who resigned his position.
“It humbles me to join a company such as Axim Biotech that continues to prove itself as a cannabis pharmaceutical industry leader and prioritizes the quality of its products to bring consumers top-tier treatments,” said Mauricio Javier Gatto-Bellora, Member of the Board of Directors. “As Axim continues its international expansion, my previous business background will drive me to assist the company in achieving its goals.”